Cargando…

EZH2 identifies the precursors of human natural killer cells with trained immunity

OBJECTIVE: Trained immunity of natural killer (NK) cells has shown great potential in the treatment of cancers by eliciting enhanced effector responses to restimulation by cytokines or cancer cells for long time periods after preactivation. However, the human NK cells responsible for the generation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chen, Yin, Jie, Zheng, Jian, Xiao, Jun, Hu, Jiajian, Su, Yudong, Zhou, Kaichen, Zhang, Yingchi, Zhang, Xuzhen, Zhang, Hong, Sun, Qian, Wang, Yang, Yu, Wenwen, Wei, Feng, Zhao, Qiang, Li, Long, Ren, Xiubao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610163/ https://www.ncbi.nlm.nih.gov/pubmed/34553850 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0791

Ejemplares similares

Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
por: Tian, Xiao, et al.
Publicado: (2017)

EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
por: Li, Boheng, et al.
Publicado: (2023)

Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer
por: Cui, Yanan, et al.
Publicado: (2023)

The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD(3)+CD(56)+ NKT-Like Cells
por: Zhu, Siyu, et al.
Publicado: (2022)

Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer
por: Li, Man, et al.
Publicado: (2018)

Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients
por: Zhang, Lin, et al.
Publicado: (2016)

Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line
por: Yang, Lili, et al.
Publicado: (2017)

Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
por: Hui, Zhenzhen, et al.
Publicado: (2015)

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
por: Dai, Kai, et al.
Publicado: (2021)

Identification of CD4(−)CD8(−) Double-Negative Natural Killer T Cell Precursors in the Thymus
por: Dashtsoodol, Nyambayar, et al.
Publicado: (2008)

Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor
por: Cheung, Phyllis FY, et al.
Publicado: (2015)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
por: Colomar-Carando, Natalia, et al.
Publicado: (2022)

Trace Evidence: Identifying Natural Cancer Killers After the Crime
por: Schafer, Jolie R., et al.
Publicado: (2015)

Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity
por: He, Shan, et al.
Publicado: (2017)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Natural killer cells in obstetric antiphospholipid syndrome
por: Huo, Rongxiu, et al.
Publicado: (2022)

EZH2 is a potential prognostic predictor of glioma
por: Chen, Yi‐nan, et al.
Publicado: (2020)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia
por: Danis, Etienne, et al.
Publicado: (2016)

Sjögren's Syndrome Complicated by Myeloid/Natural Killer Cell Precursor Acute Leukemia: Case Report and Review of the Literature
por: Feng, Hao, et al.
Publicado: (2016)

Non-coding RNAs in Natural Killer/T-Cell Lymphoma
por: Mei, Mei, et al.
Publicado: (2019)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Alzheimer’s disease alters the transcriptomic profile of natural killer cells at single-cell resolution
por: Qi, Caiyun, et al.
Publicado: (2022)

Stress Signals Activate Natural Killer Cells
por: Long, Eric O., et al.
Publicado: (2002)

The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990)

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
por: Grimm, EA, et al.
Publicado: (1983)

Natural Born Killers
Publicado: (1998)

Natural born killers.
por: Schmidt, C W
Publicado: (1998)

Natural killer T cells
por: Kanellopoulos, Jean
Publicado: (2015)

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2022)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures
Publicado: (1990)

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
por: Liu, Liang, et al.
Publicado: (2020)

RIP-Seq of EZH2 Identifies TCONS-00036665 as a Regulator of Myogenesis in Pigs
por: Wang, Shanshan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ckssk2upncah7tlsv4st8jpr1b